Acetic Acid

Acetic Acid

SCHEMBL8329829

CC(=O)O.CC(=O)O.CC(=O)O.[Ni]

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.88
LCK P06239 1/20 0.88
FYN P06241 1/20 0.88
LMNA P02545 3/20 0.56
TSHR P16473 2/20 0.50
THPO P40225 1/20 0.50
CA1 P00915 3/20 0.46
ALOX15 P16050 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
CA2 P00918 2/20 0.44
CA9 Q16790 1/20 0.44
ALDH1A1 P00352 5/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 1/20 0.39
PTGS1 P23219 1/20 0.39
MMP12 P39900 1/20 0.39
CA4 P22748 1/20 0.39
SLC15A2 Q16348 1/20 0.38
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL1924488 1.00
Acetic Acid SCHEMBL27620004 1.00 FFAR3 (0.88) FFAR3LCKFYNLMNATSHR
Acetic Acid SCHEMBL27749762 1.00
Acetic Acid SCHEMBL7920768 1.00 FFAR3 (0.88) FFAR3LCKFYNLMNATSHR
Acetic Acid SCHEMBL66265 1.00
Acetic Acid SCHEMBL8574099 0.94 FFAR3 (0.78) FFAR3LCKFYNLMNATSHR
Acetic Acid SCHEMBL1142956 0.94
Acetic Acid SCHEMBL1971539 0.94
Acetic Acid SCHEMBL11411038 0.94 FFAR3 (0.78) FFAR3LCKFYNLMNATSHR
Acetic Acid SCHEMBL11574109 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117305286-B Application of patchouli enolase PcENO3 in preparation of product for regulating patchouli alcohol biosynthesis 广州中医药大学(广州中医药研究院) 2026-05-15 CN disclosed
CN-118221957-A Preparation method and application of bimetal CPs monocrystal 四川大学 2024-06-21 CN disclosed
CN-117305286-A Application of patchouli enolase PcENO3 in preparation of product for regulating patchouli alcohol biosynthesis 广州中医药大学(广州中医药研究院) 2023-12-29 CN disclosed
CN-116829724-A Optically controlled viral transduction 阿尔贝特-路德维希斯弗赖堡大学 2023-09-29 CN disclosed
CN-116113401-A Antibody-bound nanoparticles 华盛顿大学 2023-05-12 CN disclosed
CN-113117748-B Bicyclic guanidine salt eutectic solvent catalyst and preparation method and application thereof 南京大学 2022-06-07 CN disclosed
CN-113117748-A Bicyclic guanidine salt eutectic solvent catalyst and preparation method and application thereof 南京大学 2021-07-16 CN disclosed
CN-102448982-B For adjusting the active composition and method of Complement Regulatory Protein on target cell 华盛顿大学 2018-04-20 CN disclosed
CN-105586141-A Grinding fluid for machining WUXI HUAYE IRON & STEEL CO LTD 2016-05-18 CN disclosed
US-20130126794-A1 CARBON NANOFIBER CONTAINING METAL OXIDE OR INTERMETALLIC COMPOUND, PREPARATION METHOD THEREOF, AND LITHIUM SECONDARY BATTERY USING SAME INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) 2013-05-23 US disclosed
EP-0714399-A4 HSV-2 UL26 GENE, CAPSID PROTEINS, IMMUNOASSAYS AND PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 1999-01-27 EP disclosed
EP-0714399-A1 HSV-2 UL26 GENE, CAPSID PROTEINS, IMMUNOASSAYS AND PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1996-06-05 EP disclosed
WO-1995006055-A1 HSV-2 UL26 GENE, CAPSID PROTEINS, IMMUNOASSAYS AND PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1995-03-02 WO disclosed
US-4337335-A Transition metal salt complexes of polyamino organic compounds SCHERING CORPORATION (US) 1982-06-29 US disclosed
US-4234628-A Two-step preplate system for polymeric surfaces THE HARSHAW CHEMICAL COMPANY (US) 1980-11-18 US disclosed
US-4230847-A Aminoglycoside antibiotic compounds SCHERING CORPORATION (US) 1980-10-28 US disclosed
US-4136254-A PROCESS OF SELECTIVELY BLOCKING AMINO FUNCTIONS IN AMINOGLYCOSIDES USING TRANSITION METAL SALTS AND INTERMEDIATES USED THEREBY SCHERING CORPORATION (US) 1979-01-23 US disclosed